Paper35836722
Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment.
Fu XX and 6 others. J Inflamm Res, 2022. Cited by 2 papers, by iCite.
Cite this record
ConductScience Library. Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment. Papers, record 35836722. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/35836722
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Co-Application of C16 and Ang-1 Improves the Effects of Levodopa in Parkinson Disease Treatment.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References32
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17401348 | Protocol for the MPTP mouse model of Parkinson's disease. | Nat Protoc | 2007 | https://conductscience.org/library/papers/17401348 | PubMed |
| 2 | 28649132 | Reassessment of subacute MPTP-treated mice as animal model of Parkinson's disease. | Acta Pharmacol Sin | 2017 | https://conductscience.org/library/papers/28649132 | PubMed |
| 3 | 31686637 | Parkinson's Disease: A Review from Pathophysiology to Treatment. | Mini Rev Med Chem | 2020 | https://conductscience.org/library/papers/31686637 | PubMed |
| 4 | 31445160 | Dystonia and levodopa-induced dyskinesias in Parkinson's disease: Is there a connection? | Neurobiol Dis | 2019 | https://conductscience.org/library/papers/31445160 | PubMed |
| 5 | 29459656 | Electromyographic patterns of the rat hindlimb in response to muscle stretch after spinal cord injury. | Spinal Cord | 2018 | https://conductscience.org/library/papers/29459656 | PubMed |
| 6 | 31845761 | Neuroinflammation: Fanning the fire of l-dopa-induced dyskinesia. | Mov Disord | 2019 | https://conductscience.org/library/papers/31845761 | PubMed |
| 7 | 29473513 | The Role of LRRK2 in Neurodegeneration of Parkinson Disease. | Curr Neuropharmacol | 2018 | https://conductscience.org/library/papers/29473513 | PubMed |
| 8 | 28753652 | The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson's disease. | PLoS One | 2017 | https://conductscience.org/library/papers/28753652 | PubMed |
| 9 | 3164041 | Brain acetylcholinesterase activity is markedly reduced in dominantly-inherited olivopontocerebellar atrophy. | J Neurol Neurosurg Psychiatry | 1988 | https://conductscience.org/library/papers/3164041 | PubMed |
| 10 | 34625569 | Adjusting vascular permeability, leukocyte infiltration, and microglial cell activation to rescue dopaminergic neurons in rodent models of Parkinson's disease. | NPJ Parkinsons Dis | 2021 | https://conductscience.org/library/papers/34625569 | PubMed |
| 11 | 30476904 | Angiopoietin-1 and ανβ3 integrin peptide promote the therapeutic effects of L-serine in an amyotrophic lateral sclerosis/Parkinsonism dementia complex model. | Aging (Albany NY) | 2018 | https://conductscience.org/library/papers/30476904 | PubMed |
| 12 | 32247534 | Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration. | Neurobiol Aging | 2020 | https://conductscience.org/library/papers/32247534 | PubMed |
| 13 | 32739252 | Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex. | Neurobiol Dis | 2020 | https://conductscience.org/library/papers/32739252 | PubMed |
| 14 | 31494143 | Antioxidant and anti-inflammatory effects of dexrazoxane on dopaminergic neuron degeneration in rodent models of Parkinson's disease. | Neuropharmacology | 2019 | https://conductscience.org/library/papers/31494143 | PubMed |
| 15 | 24852101 | Angiopoietin-1 ameliorates inflammation-induced vascular leakage and improves functional impairment in a rat model of acute experimental autoimmune encephalomyelitis. | Exp Neurol | 2014 | https://conductscience.org/library/papers/24852101 | PubMed |
| 16 | 29257290 | Time-course behavioral features are correlated with Parkinson's disease‑associated pathology in a 6-hydroxydopamine hemiparkinsonian rat model. | Mol Med Rep | 2018 | https://conductscience.org/library/papers/29257290 | PubMed |
| 17 | 22251459 | Animal models of Parkinson's disease. | FEBS J | 2012 | https://conductscience.org/library/papers/22251459 | PubMed |
| 18 | 22465440 | Animal models of L-DOPA-induced dyskinesia: an update on the current options. | Neuroscience | 2012 | https://conductscience.org/library/papers/22465440 | PubMed |
| 19 | 32987656 | The Pathology of Parkinson's Disease and Potential Benefit of Dietary Polyphenols. | Molecules | 2020 | https://conductscience.org/library/papers/32987656 | PubMed |
| 20 | 29669582 | Galantamine improves cognition, hippocampal inflammation, and synaptic plasticity impairments induced by lipopolysaccharide in mice. | J Neuroinflammation | 2018 | https://conductscience.org/library/papers/29669582 | PubMed |
Cited by1
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.
| PMID | Title | Journal | Year | In Papers |
|---|---|---|---|---|
| 42540656 | Probiotics in Combination with C16 Peptide and Angiopoietin-1 Synergistically Ameliorate Multiple Sclerosis in Mice. | Drug Des Devel Ther | 2026 | https://conductscience.org/library/papers/42540656 |
Source PubMed
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IL6 | 3569 | PubTator's text mining | https://conductscience.org/library/genes/3569 | NCBI Gene |
| MAOB | 4129 | PubTator's text mining | https://conductscience.org/library/genes/4129 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/35836722
GET https://conductscience.org/api/papers/v1/35836722/references?page=2